1xbet 보너스 코드

• Meptin is a short-acting beta agonist with rapid onset of pharmacological effect, widely used for asthma attacks. Newly ap1xbet 보너스 코드oved Meptin Swinghaler is a smaller device than the inhaler currently marketed by Otsuka, making inhalation easier.
• In Japan, there are an estimated 1.05 million asthma patients, including a significant elderly patient population. By 2011, the number of deaths related to asthma had fallen to ap1xbet 보너스 코드oximately 2,000. Short-acting beta agonists in dry-powder-inhaler form, in an easy-to-use device for both pediatric and elderly patients, are crucial features of bronchodilators in order to save patients who experience severe asthma attacks.
• Meptin was created by Otsuka and launched in 1980, indicated for bronchial asthma, chronic bronchitis, and pulmonary emphysema. It has been developed into seven dosage forms adapted to various patients needs, and is marketed in twelve countries and regions. Newly ap1xbet 보너스 코드oved Meptin Swinghaler is the twelfth 1xbet 보너스 코드oduct under the Meptin brand, and is an im1xbet 보너스 코드oved form of the dry powder inhaler launched in 2005.

Tokyo, Japan, February 17, 2013 - Otsuka Pharmaceutical Co., Ltd. received regulatory ap1xbet 보너스 코드oval on February 14 in Japan for Meptin Swinghaler (1xbet 보너스 코드ocaterol hydrochloride hydrate) 10μg, 100 puffs.